Literature DB >> 23386271

Optical coherence tomography is superior to intravascular ultrasound for diagnosis of distal-type chronic thromboembolic pulmonary hypertension.

Shunsuke Tatebe1, Yoshihiro Fukumoto, Koichiro Sugimura, Yutaka Miura, Kotaro Nochioka, Tatsuo Aoki, Masanobu Miura, Saori Yamamoto, Nobuhiro Yaoita, Kimio Satoh, Hiroaki Shimokawa.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23386271     DOI: 10.1253/circj.cj-12-1493

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


× No keyword cloud information.
  6 in total

Review 1.  Chronic Thromboembolic Pulmonary Hypertension: the Bedside.

Authors:  Yuri Matusov; Inderjit Singh; Yen-Rei Yu; Hyung J Chun; Bradley A Maron; Victor F Tapson; Michael I Lewis; Sudarshan Rajagopal
Journal:  Curr Cardiol Rep       Date:  2021-08-19       Impact factor: 2.931

Review 2.  A GPS map for pulmonary hypertension: a review of imaging modalities.

Authors:  Jinghui Li; Ashley Lee; Yingsheng Cheng
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

Review 3.  Advances in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Authors:  Ehtisham Mahmud; Mitul Patel; Lawrence Ang; David Poch
Journal:  Pulm Circ       Date:  2021-05-24       Impact factor: 3.017

4.  Comparison of intravascular optical frequency domain imaging versus intravascular ultrasound during balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Nobutaka Ikeda; Shuji Kubota; Toru Okazaki; Hisao Hara; Yukio Hiroi
Journal:  Catheter Cardiovasc Interv       Date:  2016-03-18       Impact factor: 2.692

Review 5.  Balloon Pulmonary Angioplasty: A Treatment Option for Inoperable Patients with Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Aiko Ogawa; Hiromi Matsubara
Journal:  Front Cardiovasc Med       Date:  2015-02-17

Review 6.  Visible-light optical coherence tomography: a review.

Authors:  Xiao Shu; Lisa Beckmann; Hao Zhang
Journal:  J Biomed Opt       Date:  2017-12       Impact factor: 3.170

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.